Thermo Fisher Scientific Inc (NYSE:TMO)

555.06
Delayed Data
As of May 20
 +4.32 / +0.78%
Today’s Change
438.72
Today|||52-Week Range
672.34
-16.81%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$211.9B

Company Description

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment is involved in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industri

Contact Information

Thermo Fisher Scientific, Inc.
168 Third Avenue
Waltham Massachusetts 02451
P:(781) 622-1000
Investor Relations:
(781) 622-1356

Employees

Shareholders

Mutual fund holders50.57%
Other institutional40.21%
Individual stakeholders0.60%

Top Executives

Marc N. CasperChairman, President & Chief Executive Officer
Michel LagardeChief Operating Officer & Executive Vice President
Stephen WilliamsonChief Financial Officer & Senior Vice President
Alan B. SachsChief Medical Officer
Ryan SnyderChief Information Officer & Senior Vice President